Literature DB >> 5957288

Chediak-Higashi syndrome. Observations on the nature of the associated malignancy.

P B Dent, L A Fish, L G White, R A Good.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5957288

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  31 in total

1.  [Granulocyte dysfunction. Part II. Secondary defects. (authors transl)].

Authors:  D Niethammer; A Wildfeuer; E Kleihauer; O Haferkamp
Journal:  Klin Wochenschr       Date:  1975-08-15

2.  Chediak-Higashi syndrome.

Authors:  J E Cree; T P Mann; A D Webster; G L Asherson
Journal:  Proc R Soc Med       Date:  1975-05

3.  Lymphoreticular tissue lesions in Steinbrinck-Chediak-Higashi syndrome.

Authors:  G R Krüger; V Bedoya; P M Grimley
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1971

4.  Genetics and infection.

Authors: 
Journal:  Br Med J       Date:  1969-11-08

Review 5.  Natural killer cells in resistance to virus-infected cells.

Authors:  B Rager-Zisman; B R Bloom
Journal:  Springer Semin Immunopathol       Date:  1982

Review 6.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

Review 7.  Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.

Authors:  E Gleichmann; H Gleichmann
Journal:  Klin Wochenschr       Date:  1973-03-15

Review 8.  Tumor cells do not arise frequently.

Authors:  W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  The Chédiak-Higashi syndrome: CT and MR findings.

Authors:  R Ballard; R D Tien; V Nohria; V Juel
Journal:  Pediatr Radiol       Date:  1994

10.  Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.

Authors:  T Abo; J C Roder; W Abo; M D Cooper; C M Balch
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.